{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-290726","form_type":"8-K","ticker":null,"cik":"0001851194","company_name":"Ventyx Biosciences, Inc.","filed_at":"2023-12-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.051076+00:00","generated_at":"2026-06-07T16:25:14.092562+00:00","sec_items":["2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Ventyx Biosciences reduces workforce by ~20%, expects $2.0M severance costs","bullets":["Reduction in force impacts approximately 20% of the company's workforce.","Estimated total severance and benefit expenses of $2.0 million.","Additional charges may be incurred; details to follow in 2023 10-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-290726","json":"https://secwatch.observer/filing/0001193125-23-290726.json","markdown":"https://secwatch.observer/filing/0001193125-23-290726.md","text":"https://secwatch.observer/filing/0001193125-23-290726.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851194/000119312523290726/0001193125-23-290726-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851194/000119312523290726/d548412d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T16:25:14.092562+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1005623abe3ac06ac99d125c492436ec9cb6f4f6","claim":"Ventyx Biosciences, Inc. announced a restructuring with charges of approximately $2.0 million (approximately 20% of the Company’s workforce).","evidence_excerpt":"On December 5, 2023, Ventyx Biosciences, Inc. (the “Company”), committed to and implemented a reduction in force that impacted approximately 20% of the Company’s workforce. The Company expects to recognize approximately $2.0 million in total expenses for severance and related benefits for employees laid off under the reduction in force, consisting primarily of severance payments and continued healthcare benefits for a specific period of time.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1851194/000119312523290726/0001193125-23-290726-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $2.0 million"},{"label":"Headcount","value":"approximately 20% of the Company’s workforce"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}